stockrowElevance Health, Inc.
ELV Healthcare Healthcare Plans
Elevance Health, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $199.1 billion, up 12.5% from fiscal 2024.
- Revenue
- +1.42%
- EPS
- +17.9%
- Free cash flow
- +29.0%
- Total debt
- −3.65%
Quarter to September 2026, against a year earlier
Follow ELV
Alert me
Elevance Health, Inc. (ELV) Return on equity
Elevance Health, Inc.'s return on equity over the twelve months to 30 September 2026 was 11.6%, down 1.7 percentage points from fiscal 2025 (13.3%). Over the past ten years it has ranged from 10.3% (fiscal 2016) to 17.8% (fiscal 2021); the current reading is higher than 27% of that period. That is below the Healthcare Plans industry median of 13.6% and above the Healthcare sector median of −26.0%.
Return on equity, annual
Embed this chart
Annual newest first
| Period | Return on equity | Change (points) |
|---|---|---|
| FY2025 | 13.3% | (1.55) |
| FY2024 | 14.8% | (1.01) |
| FY2023 | 15.8% | (0.46) |
| FY2022 | 16.3% | (1.50) |
| FY2021 | 17.8% | 3.69 |
| FY2020 | 14.1% | (1.87) |
| FY2019 | 16.0% | 2.32 |
| FY2018 | 13.6% | (1.26) |
| FY2017 | 14.9% | 4.63 |
| FY2016 | 10.3% | (0.57) |
Against its own ten years
Return on equity against peers
| Company | Return on equity |
|---|---|
| OSCR Oscar Health, Inc. compare | 52.6% |
| PGNY Progyny, Inc. compare | 18.7% |
| UNH UnitedHealth Group Incorporated compare | 15.4% |
| CVS CVS Health Corporation compare | 14.4% |
| CI Cigna Group compare | 14.0% |
| ELV Elevance Health, Inc. | 11.6% |
| CNC Centene Corporation compare | 6.74% |
| HUM Humana Inc. compare | 6.65% |
| MOH Molina Healthcare, Inc compare | −1.15% |
| Healthcare Plans industry median | 13.6% |
| Healthcare sector median | −26.0% |
| Market median | 1.01% |
What Return on equity is
ROE shows how much profit a company earns for its shareholders on the equity they have in the business.
Annual: Net Income Allotted to Shareholders ÷ Average Common Equity; TTM: Net Income Allotted to Shareholders ÷ Average Common Equity (latest quarter)
More on ELV
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement